Recent Prototype Drug Development: Insights in Protein Science and Enzymology for Precision Medicine
A special issue of Biology (ISSN 2079-7737).
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 6692
Special Issue Editors
2. Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Avenida de Universidade, Taipa, Macau SAR, China
3. Ministry of Education (MoE) Frontiers Science Center for Precision Oncology, University of Macau, Avenida de Universidade, Taipa, Macau SAR, China
Interests: novel therapeutic antibodies development; venom-based peptide & natural biomolecule prototype drugs development; cancer biomarkers & immunotherapy markers discovery for prognostic and therapeutic validation
Special Issues, Collections and Topics in MDPI journals
Interests: peptide science; antibiotic resistance; structure–activity relationship; drug design
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The specificity and precise mechanisms of drugs are crucial in reducing the severity of side effects associated with their use. Adverse effects may require that the drug dosages be reduced or the drug regimen be changed such that the drugs tolerable to patients. As we are enter the third decade of the 21st century, the achievements made by biomedical scientists and pharmaceutical institutes/companies have been exceptional in the last decade, leading to significant advancements in the fast-growing field of druggable target identification for drug screening and development via advanced protein science and enzymology research.
We are pleased to invite you to contribute research and/or review articles on the latest developments in molecular pharmacology and enzymology research in the precision medicine era. We aim to bring leading researchers together to exchange and share their recent findings in molecular pharmacology, prototype drug development, and precision medicine for different disease treatments.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but not limited to) the following:
- Molecular pharmacology
- Precision medicine
- Druggable genes
- Signal inhibition
- Immune checkpoint inhibitors
- Stress tolerance
- Drug resistance
- Network pharmacology
- Predictive biomarkers
We look forward to receiving your contributions.
Prof. Dr. Hang Fai (Henry) Kwok
Prof. Dr. Tianbao Chen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- targeted therapy
- therapeutic antibody
- chemotherapy
- novel bioactive molecule
- biomarker
- drug resistance
- enzymology
- molecular pharmacology
- precision medicine